Turning tissue and liquid biopsies into answers when you need them
ArcherDX is developing a new solid tumor IVD designed to identify actionable genomic alterations in tissue and blood samples that is intended for use as a companion diagnostic.
If approved by the FDA, the assay will be a universal in vitro diagnostic (IVD) that utilizes AMP™ chemistry to measure clinically relevant genomic mutations for tumor profiling and companion diagnostic markers.
NOT APPROVED BY US FDA. NOT FOR DIAGNOSTIC USE. NOT FOR COMMERCIAL DISTRIBUTION.